Copyright Reports & Markets. All rights reserved.

Global Pediatric Vaccines Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Pediatric Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pediatric Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pediatric Vaccines Market Size Growth Rate by Type
    • 1.4.2 Diphtheria
    • 1.4.3 Influenza
    • 1.4.4 Hepatitis
    • 1.4.5 Pneumococcal Diseases
    • 1.4.6 Meningococcal Diseases
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Pediatric Vaccines Market Size Growth Rate by Application
    • 1.5.2 Newborn
    • 1.5.3 Infant
    • 1.5.4 Child
    • 1.5.5 Dolescent
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Pediatric Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global Pediatric Vaccines Revenue 2015-2026
    • 2.1.2 Global Pediatric Vaccines Sales 2015-2026
  • 2.2 Global Pediatric Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Pediatric Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Pediatric Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pediatric Vaccines Competitor Landscape by Players

  • 3.1 Pediatric Vaccines Sales by Manufacturers
    • 3.1.1 Pediatric Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Pediatric Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Pediatric Vaccines Revenue by Manufacturers
    • 3.2.1 Pediatric Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Pediatric Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pediatric Vaccines Revenue in 2019
    • 3.2.5 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Pediatric Vaccines Price by Manufacturers
  • 3.4 Pediatric Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Pediatric Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pediatric Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pediatric Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Pediatric Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Pediatric Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Pediatric Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Pediatric Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pediatric Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pediatric Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pediatric Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pediatric Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pediatric Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Pediatric Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Pediatric Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Pediatric Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Pediatric Vaccines Price by Application (2015-2020)
  • 5.2 Pediatric Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pediatric Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pediatric Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pediatric Vaccines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Pediatric Vaccines by Country
    • 6.1.1 North America Pediatric Vaccines Sales by Country
    • 6.1.2 North America Pediatric Vaccines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Pediatric Vaccines Market Facts & Figures by Type
  • 6.3 North America Pediatric Vaccines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Pediatric Vaccines by Country
    • 7.1.1 Europe Pediatric Vaccines Sales by Country
    • 7.1.2 Europe Pediatric Vaccines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Pediatric Vaccines Market Facts & Figures by Type
  • 7.3 Europe Pediatric Vaccines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Pediatric Vaccines by Region
    • 8.1.1 Asia Pacific Pediatric Vaccines Sales by Region
    • 8.1.2 Asia Pacific Pediatric Vaccines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Pediatric Vaccines Market Facts & Figures by Type
  • 8.3 Asia Pacific Pediatric Vaccines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Pediatric Vaccines by Country
    • 9.1.1 Latin America Pediatric Vaccines Sales by Country
    • 9.1.2 Latin America Pediatric Vaccines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Pediatric Vaccines Market Facts & Figures by Type
  • 9.3 Central & South America Pediatric Vaccines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Pediatric Vaccines by Country
    • 10.1.1 Middle East and Africa Pediatric Vaccines Sales by Country
    • 10.1.2 Middle East and Africa Pediatric Vaccines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Type
  • 10.3 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Description and Business Overview
    • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
    • 11.1.5 GlaxoSmithKline Related Developments
  • 11.2 Merck
    • 11.2.1 Merck Corporation Information
    • 11.2.2 Merck Description and Business Overview
    • 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Merck Pediatric Vaccines Products Offered
    • 11.2.5 Merck Related Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Description and Business Overview
    • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pfizer Pediatric Vaccines Products Offered
    • 11.3.5 Pfizer Related Developments
  • 11.4 Sanofi
    • 11.4.1 Sanofi Corporation Information
    • 11.4.2 Sanofi Description and Business Overview
    • 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Sanofi Pediatric Vaccines Products Offered
    • 11.4.5 Sanofi Related Developments
  • 11.5 AstraZeneca
    • 11.5.1 AstraZeneca Corporation Information
    • 11.5.2 AstraZeneca Description and Business Overview
    • 11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 AstraZeneca Pediatric Vaccines Products Offered
    • 11.5.5 AstraZeneca Related Developments
  • 11.6 Novartis
    • 11.6.1 Novartis Corporation Information
    • 11.6.2 Novartis Description and Business Overview
    • 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Novartis Pediatric Vaccines Products Offered
    • 11.6.5 Novartis Related Developments
  • 11.7 Takeda Pharmaceutical
    • 11.7.1 Takeda Pharmaceutical Corporation Information
    • 11.7.2 Takeda Pharmaceutical Description and Business Overview
    • 11.7.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Takeda Pharmaceutical Pediatric Vaccines Products Offered
    • 11.7.5 Takeda Pharmaceutical Related Developments
  • 11.8 Bavarian Nordic
    • 11.8.1 Bavarian Nordic Corporation Information
    • 11.8.2 Bavarian Nordic Description and Business Overview
    • 11.8.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Bavarian Nordic Pediatric Vaccines Products Offered
    • 11.8.5 Bavarian Nordic Related Developments
  • 11.9 Baxter
    • 11.9.1 Baxter Corporation Information
    • 11.9.2 Baxter Description and Business Overview
    • 11.9.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Baxter Pediatric Vaccines Products Offered
    • 11.9.5 Baxter Related Developments
  • 11.10 LG Life Sciences
    • 11.10.1 LG Life Sciences Corporation Information
    • 11.10.2 LG Life Sciences Description and Business Overview
    • 11.10.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 LG Life Sciences Pediatric Vaccines Products Offered
    • 11.10.5 LG Life Sciences Related Developments
  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Description and Business Overview
    • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
    • 11.1.5 GlaxoSmithKline Related Developments
  • 11.12 S K Chemicals
    • 11.12.1 S K Chemicals Corporation Information
    • 11.12.2 S K Chemicals Description and Business Overview
    • 11.12.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 S K Chemicals Products Offered
    • 11.12.5 S K Chemicals Related Developments
  • 11.13 Mitsubishi Tanabe Pharma
    • 11.13.1 Mitsubishi Tanabe Pharma Corporation Information
    • 11.13.2 Mitsubishi Tanabe Pharma Description and Business Overview
    • 11.13.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Mitsubishi Tanabe Pharma Products Offered
    • 11.13.5 Mitsubishi Tanabe Pharma Related Developments
  • 11.14 Janssen
    • 11.14.1 Janssen Corporation Information
    • 11.14.2 Janssen Description and Business Overview
    • 11.14.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Janssen Products Offered
    • 11.14.5 Janssen Related Developments
  • 11.15 Shenzhen Kangtai Biological Products
    • 11.15.1 Shenzhen Kangtai Biological Products Corporation Information
    • 11.15.2 Shenzhen Kangtai Biological Products Description and Business Overview
    • 11.15.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Shenzhen Kangtai Biological Products Products Offered
    • 11.15.5 Shenzhen Kangtai Biological Products Related Developments
  • 11.16 Sinovac Biotech
    • 11.16.1 Sinovac Biotech Corporation Information
    • 11.16.2 Sinovac Biotech Description and Business Overview
    • 11.16.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Sinovac Biotech Products Offered
    • 11.16.5 Sinovac Biotech Related Developments
  • 11.17 Bharat Biotech
    • 11.17.1 Bharat Biotech Corporation Information
    • 11.17.2 Bharat Biotech Description and Business Overview
    • 11.17.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Bharat Biotech Products Offered
    • 11.17.5 Bharat Biotech Related Developments
  • 11.18 Crucell
    • 11.18.1 Crucell Corporation Information
    • 11.18.2 Crucell Description and Business Overview
    • 11.18.3 Crucell Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Crucell Products Offered
    • 11.18.5 Crucell Related Developments
  • 11.19 Dynavax
    • 11.19.1 Dynavax Corporation Information
    • 11.19.2 Dynavax Description and Business Overview
    • 11.19.3 Dynavax Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Dynavax Products Offered
    • 11.19.5 Dynavax Related Developments
  • 11.20 Serum Institute of India
    • 11.20.1 Serum Institute of India Corporation Information
    • 11.20.2 Serum Institute of India Description and Business Overview
    • 11.20.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Serum Institute of India Products Offered
    • 11.20.5 Serum Institute of India Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Pediatric Vaccines Market Estimates and Projections by Region
    • 12.1.1 Global Pediatric Vaccines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Pediatric Vaccines Revenue Forecast by Regions 2021-2026
  • 12.2 North America Pediatric Vaccines Market Size Forecast (2021-2026)
    • 12.2.1 North America: Pediatric Vaccines Sales Forecast (2021-2026)
    • 12.2.2 North America: Pediatric Vaccines Revenue Forecast (2021-2026)
    • 12.2.3 North America: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Pediatric Vaccines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Pediatric Vaccines Sales Forecast (2021-2026)
    • 12.3.2 Europe: Pediatric Vaccines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Pediatric Vaccines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Pediatric Vaccines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Pediatric Vaccines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Pediatric Vaccines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Pediatric Vaccines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Pediatric Vaccines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Pediatric Vaccines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Pediatric Vaccines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Pediatric Vaccines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Pediatric Vaccines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Pediatric Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Pediatric Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pediatric Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Pediatric Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Pediatric Vaccines market is segmented into
    Diphtheria
    Influenza
    Hepatitis
    Pneumococcal Diseases
    Meningococcal Diseases
    Others

    Segment by Application, the Pediatric Vaccines market is segmented into
    Newborn
    Infant
    Child
    Dolescent

    Regional and Country-level Analysis
    The Pediatric Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pediatric Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Pediatric Vaccines Market Share Analysis
    Pediatric Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pediatric Vaccines business, the date to enter into the Pediatric Vaccines market, Pediatric Vaccines product introduction, recent developments, etc.

    The major vendors covered:
    GlaxoSmithKline
    Merck
    Pfizer
    Sanofi
    AstraZeneca
    Novartis
    Takeda Pharmaceutical
    Bavarian Nordic
    Baxter
    LG Life Sciences
    Lupin
    S K Chemicals
    Mitsubishi Tanabe Pharma
    Janssen
    Shenzhen Kangtai Biological Products
    Sinovac Biotech
    Bharat Biotech
    Crucell
    Dynavax
    Serum Institute of India

    Buy now